About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials | 3,965 Studies Recruiting

Clinical TrialsAlzheimer's Disease

Alzheimer's Disease Clinical Trials

Browse 3,965 clinical trials for alzheimer's disease. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 3,965 trials

CompletedRECOVERYFUN: An Integrated VR-based Tele-rehabilitation Platform to Support RECOVERY and Maintenance of FUNctional Abilities Among SeniorsThe scope of the RecoveryFun study is to test a new personalised home rehabilitation solution to leverage the telehealth paradigm and increase the possibility for seniors to…NCT06640452·Ancona RecruitingBiobank and Brain Health in Bordeaux.B cube is a new generation cohort to study the determinants and natural history of brain aging, using molecular epidemiology, in a representative sample (N=2000) of the general…NCT05322343·Bordeaux, Bordeaux RecruitingThe Swedish BioFINDER - Memory Clinic StudyThe diagnosis of diseases causing memory difficulties or dementia is often challenging.NCT06122415·Malmö

Related Searches

alzheimerstrials dementiatrials

Data from ClinicalTrials.govTerms

CompletedA Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.NCT04777409·Phoenix, Arizona and 497 others

Recruiting[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. ADStudy goal: The goal of this prospective head to head comparison is to evaluate the effectiveness of \[18F\]-MFBG PET in assessing cardiac innervation, comparing it with…NCT06120049·Ghent, Gent and 1 other

CompletedEffects of Transcranial Direct Current Stimulation on the Apathy of Alzheimer's DiseaseThis is a phase 2 double-blind, randomized, sham-controlled study to investigate the effects of repeated transcranial direct current stimulation for the treatment of apathy in…NCT01481558·São Paulo, São Paulo

UnknownPhase I Single and Multiple Escalating Dose Study of RGN1016 in Healthy Male SubjectsThis is a double-blind, randomized, placebo-controlled, dose-escalating, single dose and multiple dose study.NCT02820155·Taipei

TerminatedPhase IIa L-serine Trial for eADThis is a Phase IIa, randomized, double-blind, placebo controlled trial.NCT03062449·Lebanon, New Hampshire

CompletedEPIC: An Intervention for Early-stage AD Dyads - Adapted for Virtual DeliveryEPIC II (Early-Stage Partners in Care) is a research project designed to assist people with early-stage memory loss and their care partners by providing early-stage related…NCT03144921·Phoenix, Arizona

UnknownOn Site Sensors Monitoring Impacts of Cognitive Decline on ADLsThe purpose of this research is to compare the effectiveness of a continuous monitoring system to assess Activities of Daily Living (ADLs) over time compared to the traditional…NCT04871698·Waco, Texas

CompletedAntidepressant Medication Plus Donepezil for Treating Late-life DepressionThis study will determine the effectiveness of combining escitalopram, venlafaxine, or duloxetine with donepezil, a medication used in Alzheimer's disease, in improving memory…NCT00177671·Pittsburgh, Pennsylvania

CompletedAbility to Drive of Early Stage Alzheimer DiseaseThe main objectives of this study are: * To evaluate the driving capacities in a population of elderly subjects with early stage Alzheimer Disease (AD) in a real-life situation.NCT01566071·Reims, France

UnknownTargeting zDHHC Enzymes to Counteract Alzheimer's DiseaseAlzheimer's disease (AD) is a growing problem for aging populations worldwide and represents one of the most demanding challenges for biomedical and pharmacological research.NCT06677632·Roma

RecruitingInvestigation of Inflammation in Alzheimer's Disease and Related Dementias (ADRD) Using [11C]-CS1P1This study involves a brain positron emission tomography (PET) scan with a new, investigational radioactive tracer called \[11C\]-CS1P1 to identify inflammation in the brain by…NCT06129838·St Louis, Missouri

TerminatedIdentifying Novel Aging Targets for Treatment of DeliriumThe long-term goal of this research program is to improve understanding of the mechanistic link between Alzheimer's disease (AD) neuropathology, acute delirium, and cognitive…NCT03682874·Winston-Salem, North Carolina

CompletedEstablishment of a Bank of Biospecimens for Future Research on Age-related Cognitive DisordersThis study is collecting tissue specimens (blood, urine and saliva) from up to 1000 patients, with and without cognitive disorders, to store in the Bio Bank for future research.NCT00911690·Royal Oak, Michigan

CompletedLifestyle Remodeling in Subjective Memory Complaint (SMC): Brain Imaging and Blood Biochemistry StudyThe specific study aims: 1. To investigate whether the brain function is affected by the past life experiences, such as lifestyle and physiology-related factors in SMC.NCT04162990·Taipei, Beitou District

TerminatedStudy to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's DiseaseThis study is being done to evaluate the safety, tolerability and potential effectiveness of a new investigational drug, bryostatin 1, in patients with Alzheimer's disease (AD).NCT02221947·Glendale, California

CompletedA Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's DiseaseThe purpose of this study is to develop procedures for testing the effectiveness of curcumin on slowing Alzheimer's disease (AD) progression.NCT00164749·Shatin

CompletedMemantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: Health OutcomeThis study is a retrospective review of the data collected in a previously completed randomized, controlled trial (RCT) entitled "Memantine and Comprehensive, Individualized…NCT02854917·New York, New York

Page 1 of 199Next